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ARTICLE
DHX9 helicase promotes R-loop formation in cells
with impaired RNA splicing
Prasun Chakraborty1, Jeffrey T.J. Huang2 & Kevin Hiom 1
R-loops are stable nucleic acid structures that have important physiological functions, but
which also pose a signiﬁcant threat to genomic stability. Increased R-loops cause replication
stress and chromosome fragility and have been associated with diseases such as neurode-
generation and cancer. Although excessive R-loops are a feature of cells that are defective in
RNA processing, what causes them to form is unclear. Here, we demonstrate that DHX9
(RNA helicase A) promotes the formation of pathological and non-pathological R-loops. In
the absence of splicing factors, formation of R-loops correlates with the prolonged associa-
tion of DHX9 with RNA Polymerase II (RNA Pol II). This leads to the production of DNA–RNA
hybrid, which traps RNA Pol II on chromatin with the potential to block DNA replication. Our
data provide a molecular mechanism for the formation of R-loops that is relevant to neu-
rodegenerative diseases and cancers in which deregulated RNA processing is a feature.
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R-loops are generated during transcription when nascentRNA exits RNA polymerase and pairs with its com-plementary DNA template to form a region of
RNA–DNA hybrid and displaced single-stranded DNA
(ssDNA)1. R-loops are found in a broad range of organisms
where they function in a variety of cellular processes, including
replication of mitochondrial genomes and bacterial plasmids,
regulation of chromosome segregation2, and immunoglobulin
class-switch recombination3. In mammalian cells R-loops are
widespread, occupying as much as 5% of the genome and are
enriched at promoter and terminator regions of polyA-
dependent genes, suggesting that they might play a role in the
regulation of gene expression4,5. R-loops are also found in
rDNA and tRNA genes suggesting that they form during
transcription involving RNA Polymerases I, II, or III6.
However, R-loops can pose a signiﬁcant threat to genomic
stability in a variety of ways7,8. Firstly, the displaced single-
stranded DNA in R-loops is vulnerable to attack from the
APOBEC family of cytosine deaminases which, upon further
processing by enzymes of the base excision repair pathway,
may lead to the generation of single-stranded DNA breaks9.
Secondly, regions of transition from single-strand DNA to
double-stranded DNA at the extremities of R-loops can be
cleaved by proteins of the nucleotide excision repair pathway,
generating double-stranded DNA breaks (dsb)10. Lastly, by
impeding the progression of RNA polymerase on DNA, R-
loops increase the potential for transcription–replication con-
ﬂicts (TRC)11–14. This can lead to stalling and collapse of
replication forks and the production of one-ended dsb that are
substrates for chromosome translocations6,15,16. In humans,
increased R-loops are found in a variety of diseases that exhibit
genomic instability, including myelodysplastic syndromes17,
neurodegenerative diseases18,19, and cancers such as Ewing’s
sarcoma20.
Given the potential of R-loops to cause genomic instability,
the accumulation of these structures in cells must be tightly
regulated. Indeed, a variety of proteins have been identiﬁed that
prevent R-loops from forming. The majority of these are pro-
teins involved in ribonucleoprotein (RNP) biogenesis and pre-
mRNA processing, including several splicing factors and com-
ponents of the THO/TREX complex that couples the matura-
tion and export of pre-mRNA21,22. In both yeast and human
cells, defects in these proteins leads to the accumulation of R-
loops and increased DNA damage.
Several other proteins facilitate the removal of R-loops.
RNaseH1, for example, removes R-loops by speciﬁcally
degrading RNA–DNA hybrid23. Alternatively, helicases
including SETX (Sen1 in yeast) and AQR, disassemble R-loops
by unwinding RNA–DNA hybrid24–26. Interestingly, the DNA
repair protein BRCA2 also suppresses R-loops by promoting
release of RNA Pol II that is paused at a promoter region27,28.
However, it is unclear how these different factors regulate the
balance between formation and removal of R-loops to prevent
the pathological potential of these stable nucleic acid structures
in cells.
Although R-loops have been shown to play speciﬁc roles in
normal physiological processes and to accumulate in cells that
are defective in RNA metabolism, it is still unclear what causes
R-loops to form and whether this requires the activities of
speciﬁc proteins. We investigated the role of splicing factors in
R-loop-induced replication stress and identiﬁed the RNA
helicase, DHX9, as a key factor in the generation of R-loops by
RNA Polymerase II. Our data shed new light on the mechanism
through which R-loops are formed and the important role
played by splicing factors to prevent R-loop induced replication
stress and genomic instability.
Results
Defects in SFPQ cause R-loop induced DNA replication stress.
An increasing number of proteins that function in RNA meta-
bolism have also been shown to contribute to the maintenance of
genomic stability29. Among these are members of the Drosophila
Behavior and Human Splicing (DBHS) family of proteins, which
are found in subnuclear bodies called paraspeckles30. Although
DBHS proteins are required for the retention and processing of
hyper-edited RNAs, some also play a role in the repair of dsb by
homologous recombination and non-homologous end-
joining31,32. We focused on one of these, SFPQ (splicing factor
proline and glutamine rich), and found that it promotes genomic
stability by preventing the formation of R-loops.
Homozygous deletion of Sfpq in mice is embryonically lethal33.
Accordingly siRNA-mediated knockdown of SFPQ in U2OS cells
(Fig. 1a) led to impaired cell growth (Fig. 1b) and increased
apoptotic cell death (Fig. 1c), conﬁrming that it is essential for cell
viability. Importantly, viability was restored by exogenous
expression of an siRNA-resistant SFPQ-myc gene in these cells
(Fig. 1b). Several pieces of evidence indicated that this defect in
cell proliferation was caused by impaired DNA synthesis. Firstly,
knockdown of SFPQ led to a reduction in the number of S-phase
cells compared to the control populations (Fig. 2a). Secondly,
depletion of SFPQ induced severe replication stress, characterized
by the production of excessive single-stranded DNA (RPA foci)
(Fig. 2b), increased DNA double-stranded breaks (γH2AX foci)
(Fig. 2c), and phosphorylation of the single-strand binding
protein RPA32 (Fig. 2d). Thirdly, we observed activation of the
replication checkpoint as indicated by phosphorylation of Chk1, a
substrate of the ATR checkpoint kinase (Fig. 2d). Lastly, SFPQ-
depleted cells were unable to efﬁciently incorporate the nucleotide
analog EdU (5-ethynyl-2′-deoxyuridine) into DNA (Fig. 3a),
indicating a failure in DNA synthesis. Importantly, replication
stress (Fig. 2b) and DNA synthesis (Fig. 3b) were rescued by over-
expressing siRNA-resistant SFPQ-myc cDNA in cells.
Although SFPQ plays a role in RNA processing, several pieces
of evidence argued that the replication stress, which accompanied
knockdown of SFPQ, was not caused by impaired expression of
proteins required in DNA synthesis. Firstly, treatment of wild-
type cells with the transcription inhibitor actinomycin D did not
generate the increased RPA foci that were evident in SFPQ-
defective cells (Supplementary Fig. 1a), nor did it impair DNA
synthesis (Supplementary Fig. 1b). Secondly, actinomycin D
treatment diminished RPA staining (Supplementary Fig. 1a) and
partially restored DNA replication (Supplementary Fig. 1a) in
SFPQ-depleted cells, indicating that replication stress caused by
defects in SFPQ requires active transcription. Lastly, replication
stress in SFPQ-depleted cells closely resembled that caused by
hydroxyurea, a potent inhibitor of DNA synthesis, which causes
replication forks to stall and collapse (Supplementary Fig. 1a).
Intriguingly, SFPQ is also a component of the spliceosome C
complex that is required for the formation of RNA lariats during
pre-mRNA splicing31. Defects in RNA splicing factors, such as
ASF/SRSF1, lead to increased genomic instability resulting from
the formation of R-loops22. Therefore, we next investigated
whether the replication stress and impaired cell growth in SFPQ-
depleted cells was also linked to the generation of R-loops. To do
this, we used S9.6 antibody34 to detect and quantify the
RNA–DNA hybrid component of R-loops. Using S9.6 in
ﬂuorescence imaging (Supplementary Fig. 2a) and slot blot
hybridization (Supplementary Fig. 2b), we observed that loss of
SFPQ was accompanied by a signiﬁcant increase in RNA–DNA
hybrids that was reversed by expressing siRNA-resistant SFPQ-
myc (Supplementary Fig. 2c). This was also true in cells treated
with the splicing inhibitor Pladeinolide B (Pla-B) and in cells
knocked down for splicing factor SF3B3, the protein targeted by
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Pla-B35(Fig. 4a). In both cases RNA–DNA hybrids were
increased, leading to impaired DNA synthesis (Fig. 4b). Impor-
tantly, R-loops were diminished upon the transient expression of
RNaseH1 (Supplementary Fig. 2d), which degrades RNA–DNA
hybrids, or by treating cells with the transcription inhibitor
actinomycin D (Supplementary Fig. 2c). These data conﬁrm the
importance of the splicing machinery generally and SFPQ,
speciﬁcally, in preventing the formation of R-loops and promot-
ing genomic stability in cells.
R-loop formation requires DHX9 helicase. An important
question arising from our data was how do RNA processing
factors, such as SFPQ, prevent R-loops from forming? Recently,
we and others found that SFPQ co-immunoprecipitated from
nuclear cell extracts with the DExH-type helicase DHX9, as
detected by western blot (Fig. 5a)36 and conﬁrmed by mass
spectrometry (Supplementary Fig. 3). Although both proteins
bind RNA, the interaction between DHX9 and SFPQ was not
mediated by RNA as it was resistant to treatment with RNase A
(Fig. 5a).
Although DHX9 has been implicated in many fundamental
cellular processes including DNA replication, transcription, and
genome stability, its speciﬁc biological function remains
unclear37. Nevertheless, we were intrigued by the fact that
DHX9 can unwind short (seventeen nucleotide) RNA–DNA
hybrids in vitro38 and hypothesized that if it also unwinds
RNA–DNA hybrid in vivo, knockdown of DHX9 should lead to
increased R-loop formation. However, when DHX9 was depleted
in U2OS cells, we observed no increase in R-loops (Fig. 4a,
Supplementary Fig. 2b) and both DNA replication (Fig. 4b) and
cell growth (Fig. 5b) were normal. Therefore, unlike SFPQ, DHX9
did not contribute to the prevention of R-loops.
However, when SFPQ and DHX9 were knocked down
simultaneously, R-loops were suppressed (Fig. 4a) and replication
stress (Fig. 5c) was alleviated compared to cells defective in SFPQ
alone. Moreover, DNA synthesis (Fig. 4b) and cell proliferation
(Fig. 5b) were restored to near wild-type levels in these cells. This
indicated that in cells lacking SFPQ, DHX9 promotes the
formation of R-loops. Importantly, the contribution of DHX9
to the production of R-loops and associated replication stress was
not limited to cells defective in SFPQ. Depletion of DHX9 also
suppressed R-loops (Fig. 4a) and restored DNA replication
(Fig. 4b) in cells treated with Pla-B or depleted of SF3B3. This led
us to two important conclusions. Firstly, in cells defective in RNA
splicing the formation of R-loops is dependent on DHX9.
Secondly, that by promoting the formation of R-loops, DHX9
contributes to the pathological replication stress caused by
perturbations in RNA splicing.
R-loops form along the coding region of the beta-actin gene.
To determine how R-loops form at a speciﬁc gene, we used S9.6
antibody for DNA–RNA immunoprecipitation (DRIP) analysis at
the Β-actin locus (Fig. 6a). This conﬁrmed that knockdown of
SFPQ causes a signiﬁcant increase in RNA–DNA hybrids com-
pared to control cells (Fig. 6b). Moreover, it revealed that
RNA–DNA hybrids can form along the entire length of the gene
coding region, beginning upstream of the Β-actin promoter,
extending through the gene body and terminating downstream of
the polyA site (Fig. 6b). Hence, the formation of RNA–DNA
hybrids probably begins early in transcription and continues
throughout elongation until transcription is terminated. Inter-
estingly, we detected a second peak of RNA–DNA hybrids
downstream from the polyadenylation site (region E) (Fig. 6b),
which might reﬂect transcripts that have undergone 3′end-pro-
cessing. Importantly, knockdown of DHX9 suppressed the
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formation of RNA–DNA hybrids across the whole coding region,
conﬁrming our hypothesis that the generation of R-loops in
SFPQ-defective cells is dependent on DHX9.
We also detected a basal level of RNA–DNA hybrids at the Β-
actin locus in control cells. These too were diminished after
knockdown of DHX9 (Fig. 6b), suggesting that DHX9 is also
involved in mechanisms leading to the low-level R-loops formed
during transcription in normal cells.
DHX9 promotes the formation of non-pathological R-loops.
Previous studies have shown that knockdown of XRN2, an
exoribonuclease required in 3′ processing of mRNA, also leads to
an accumulation of R-loops. Intriguingly, the recruitment of
XRN2 to nascent RNA is dependent on a complex comprising
SFPQ and p54nrb, raising the possibility that SFPQ and XRN2
function together to prevent R-loop formation39. However, we
found, in contrast with a previous study40, that depletion of
XRN2 induced the generation of R-loops (Supplementary
Fig. 4a), particularly at the 3′ coding and termination regions
(Supplementary Fig. 4b), but did not inhibit DNA synthesis
(Supplementary Fig. 4c), nor did it impair cell growth (Supple-
mentary Fig. 4d). In fact, incorporation of EdU into DNA was
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enhanced in cells knocked down for XRN2, compared with
control cells (Supplementary Fig. 4c). This suggested that the
contribution of SFPQ to R-loop formation must be independent
of its physical association with XRN2. Moreover, it showed that
the R-loops formed in cells knocked down for XRN2 did not
cause pathological effects on DNA replication. Interestingly, these
R-loops were also suppressed by knockdown of DHX9 (Supple-
mentary Fig. 4a).
Although perturbations in RNA processing often lead to R-
loops that are deleterious for DNA replication and cell growth,
R-loops that play a role in normal cell processes are, presumably,
not harmful. It was reported recently that R-loops found at
chromosome centromeres cause the local activation of ATR,
which regulates phosphorylation of the mitotic regulator protein
Aurora B during chromosome segregation2. To determine if
DHX9 was also required in the formation of these R-loops we
performed DRIP on centromeric DNA and DNA in the ﬂanking
arms of chromosome 1. As expected, RNA–DNA hybrid was
enriched at the centromeric DNA of chromosome 1, but not in its
ﬂanking arms (Fig. 6c). Critically, knockdown of DHX9 sup-
pressed centromeric RNA–DNA hybrid, conﬁrming that these
naturally occurring R-loops are also generated through a
mechanism involving DHX9.
Requirement for the ATP-dependent helicase function of
DHX9. We next addressed the mechanism through which DHX9
promotes R-loop formation. In vitro, DHX9 unwinds a variety of
nucleic acid structures in reactions that are dependent on ATP
hydrolysis38,41. To determine if the helicase activity of DHX9 is
required in cells to generate R-loops, we transfected an siRNA-
resistant-GFP-tagged wild-type DHX9 (GFP-DHX9) and a heli-
case/ATPase-dead mutant of DHX9 (GFP-DHX9dead) into cells
knocked down for the endogenous DHX9 and SFPQ genes.
Whereas expression of GFP-DHX9 rescued R-loop formation in
siSFPQsiDHX9 double-knockdown cells (Fig. 7a), leading to
inhibition of DNA replication and impaired cell growth (Fig. 7b),
expression of the GFP-DHX9dead mutant did not (Fig. 7). This
conﬁrmed that the ATP-dependent unwinding activity of DHX9
is essential for the generation of R-loops in SFPQ-depleted cells.
DHX9 promotes binding of splicing factors to nascent RNA.
DHX9 unwinds short RNA–DNA hybrids in vitro, suggesting
that it might prevent R-loops from forming in cells38. However,
our data established that DHX9 is required for the formation of
R-loops in cells and, therefore, that RNA–DNA hybrid is unlikely
to be the physiological substrate for DHX9 unwinding activity.
However, DHX9 also unwinds quadruplex RNA in vitro38,41 and
in cells has been shown to promote splicing of the GluR-B gene
by unwinding an inhibitory RNA stem–loop, suggesting that its
physiological substrate is most likely RNA secondary structures42.
We speculated that DHX9 might promote R-loop formation by
unwinding the nascent RNA strand to generate a free RNA end
that can invade duplex DNA to form RNA–DNA hybrid43. We
further hypothesized that in normal cells this activity might
facilitate the binding of RNA processing proteins, such as splicing
factors to nascent RNA.
To test this, we immunoprecipitated RNA Pol II from wild-
type cells that were depleted of DHX9, and looked for co-
puriﬁcation of splicing factors SFPQ, SRSF1, and SF3B3 (Fig. 7c).
In normal cells we found that all three splicing factors co-
precipitated with RNA Pol II. We conﬁrmed that these
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interactions were mediated through RNA by showing that they
were diminished in samples treated with RNaseA. However, in
cells knocked down for DHX9, co-puriﬁcation of SFPQ, SRSF1,
and SF3B3 with RNA Pol II was greatly reduced, supporting our
hypothesis that DHX9 facilitates the assembly of splicing factors
on nascent RNA during transcription.
Prolonged interaction of DHX9 with the RNA Pol II. In normal
cells, DHX9 helicase activity promotes the assembly of splicing
factors onto nascent RNA and, in the absence of splicing factors,
it promotes the formation of R-loops. These data led us to
hypothesize that the assembly of splicing factors on nascent RNA
strand might be a critical event that prevents R-loops from
forming. Therefore, we investigated whether the availability of
splicing factors affected DHX9 function during transcription and
how this might be related to the generation of R-loops.
In cells, binding of splicing factors to pre-mRNA and the
removal of introns occurs concurrently with transcription and is
coordinated through interactions between the splicing machinery
and the carboxy-terminal domain (CTD) of RNA Pol II44. These
interactions are regulated through the phosphorylation of the
CTD on different serine residues at different stages of transcrip-
tion45. RNA Pol II that is phosphorylated on serine 5 of the CTD
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(S5P) is enriched at promoter regions and diminishes towards the
3′ end of the genes, while serine 7 phosphorylation (S7P) remains
high throughout transcription. On the other hand, phosphoryla-
tion on serine 2 of the CTD (S2P) is low at promoter regions and
increases progressively toward the 3′ end of genes44.
We immunoprecipitated different phosphorylated forms of
RNA Pol II and looked for co-precipitation of DHX9. In control
cells, DHX9 co-puriﬁed primarily with S5P (Fig. 8a) and to a
small extent with S7P (Supplementary Fig. 5a), but not with S2P
(Fig. 8a). This indicated that DHX9 associated with RNA Pol II
early in transcription, but dissociated at some point during
elongation. In cells depleted for either SFPQ (Fig. 8a) or SF3B3
(Supplementary Fig. 5b), DHX9 co-precipitated primarily with
S2P but not with S5P, implying that perturbation of RNA splicing
caused DHX9 to remain associated with the transcription
complex throughout elongation until termination. Importantly,
exogenous expression of a siRNA-resistant form of SFPQ re-
established the association of DHX9 with S5P and diminished its
association with S2P (Fig. 8b).
Chromatin immunoprecipitation (ChIP) of DHX9 and RNA
Pol II at the Β-actin locus conﬁrmed that, in the absence of SFPQ,
both DHX9 (Fig. 8c) and RNA Pol II (Fig. 8d) were highly
enriched at the polyA/termination site of the gene. Importantly,
expression of RNA Pol II or DHX9 in these cells was unaffected
by knockdown of SFPQ (Supplementary Fig. 5c). These data,
together with our DRIP experiments, establish that in the
presence of SFPQ and SF3B3, DHX9 dissociates from RNA Pol
II during transcription elongation. In the absence of SFPQ or
SF3B3, DHX9 and RNA Pol II remain closely associated
throughout transcription and this correlates with the formation
of RNA–DNA hybrids across the entire length of the Β-actin
coding sequence.
Tethering of RNA Pol II to chromatin by RNA–DNA hybrid.
Although defects in pre-mRNA processing leads to the generation
of extensive tracts of RNA–DNA hybrids, recent evidence sug-
gests that R-loops, by themselves, do not necessarily cause
genomic instability46. Furthermore, while some R-loops elicit a
pathological response in cells, others do not, suggesting that only
a subset of R-loops are harmful to cells. The reason for this is not
clear.
Our experiments revealed that knockdown of SFPQ not only
promoted the formation of R-loops across the entire Β-actin
coding sequence but also caused RNA Pol II to accumulate at the
polyA site of the gene. We speculated that the formation of an
extended region of RNA–DNA hybrid might impede the
dissociation of RNA Pol II from DNA upon termination. This
might also increase the potential for TRC and lead to replication
fork collapse and increased DNA breaks.
To test this idea, we prepared nuclear extracts from wild-type
cells and from cells depleted for SFPQ and SF3B3 and examined
the presence of RNA Pol II S2P and DHX9 in the soluble nuclear
and insoluble chromatin fractions. Western blot conﬁrmed that
in extracts prepared from wild-type cells, RNA Pol II S2P and
DHX9 were present in the soluble nuclear fraction (Fig. 9a).
However, upon depletion of either SFPQ or SF3B3 (Supplemen-
tary Fig. 5d), RNA Pol II S2P and DHX9 were greatly enriched in
the insoluble pellet, indicating their retention on chromatin
(Fig. 9a). Moreover, RNA Pol II was released from chromatin by
treating pellets with RNaseH1, suggesting that RNA Pol II was
tethered to chromatin by RNA–DNA hybrid (Fig. 9a). Consistent
with this hypothesis, knockdown of DHX9 in SFPQ-depleted cells
to suppress R-loops prevented the retention of RNA Pol II on
chromatin (Fig. 9b).
Interestingly, R-loops formed upon knockdown of XRN2,
which do not impair DNA replication, did not cause retention of
RNA Pol II on chromatin (Fig. 9c). We suspected, therefore, that
it might be the tethered RNA Pol II, rather than RNA–DNA
hybrid per se, that blocks DNA synthesis in cells, leading to
pathological replication stress and chromosome instability.
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We inferred that R-loops formed as a consequence of impaired
RNA splicing may involve extensive regions of RNA–DNA
hybrids that cause RNA Pol II to be tethered to chromatin where
it can block replication and cause genomic instability. R-loops,
such as those formed in cells that are depleted of XRN2, which
may involve less extensive regions of RNA–DNA hybrid, do not
cause retention of RNA Pol II on chromatin and might not lead
to the pathological inhibition of DNA replication. Therefore,
although pathological and non-pathological R-loops can be
formed through a common mechanism involving DHX9, their
impact on DNA replication and on genomic instability is
probably context-dependent and might also be inﬂuenced by
other factors.
Discussion
Although R-loops are required for normal physiological pro-
cesses, very little is known about how and why they are generated.
The demonstration by others that proteins involved in RNA
splicing and biogenesis of RNP can suppress R-loop formation
established an important link between the generation of R-loops
and co-transcriptional processing of pre-mRNA3. Our work has
now identiﬁed DHX9 as a key protein that is required for the
formation of, at least, some R-loops and revealed how compo-
nents of the splicing machinery prevent R-loops from forming by
modulating the activity of DHX9 during transcription.
We have shown that DHX9 is required for the formation of R-
loops in cells that are defective in splicing factors SF3B3 and
SFPQ as well as those treated with the spliceosome inhibitor Pla-
B. In the absence of DHX9, the generation of R-loops in these
cells is almost entirely suppressed, restoring DNA synthesis and
cell growth. This conﬁrms the potential of some R-loops to cause
profound replication stress and, more importantly, establishes
DHX9 as an important driver of R-loop formation and genomic
instability in cells.
In addition to the R-loops that arise as a consequence of per-
turbed RNA processing, non-pathological R-loops are found
throughout the genomes of normal cells6,8. Although, we did not
address the impact of DHX9 on R-loops globally, we found that
the low level of RNA–DNA hybrids that form at the Β-actin locus
in unperturbed cells are also suppressed by knockdown of DHX9.
Furthermore, we demonstrated that R-loops generated in cen-
tromeric DNA, which regulate segregation of chromosomes
during mitosis, are also dependent on DHX9 for their formation.
Together these data strongly argue that, at least some, patholo-
gical and non-pathological R-loops are formed through a com-
mon mechanism involving DHX9.
Interestingly, DHX9 was recently identiﬁed as a component of
a RNA–DNA hybrid interactome and shown to suppress R-loops
at transcription termination regions and also prevent R-loop
associated-DNA damage in cells treated with camptothecin
(CPT)47. Paradoxically, this study, like our own, reported that
siRNA-mediated knockdown of DHX9 caused a global reduction
in RNA–DNA hybrids when measured by immunoﬂuorescence
and slot blot47, supporting our conclusion that DHX9 promotes
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rather than prevents the formation of R-loops. The reasons for
this difference are not clear but it is possible that R-loops induced
upon treatment with CPT are generated through a different
mechanism to those formed as a consequence of impaired RNA
processing.
Although DHX9 unwinds RNA–DNA hybrids in vitro38,
suggesting that it could function in the removal of R-loops, we
have established that, in cells, DHX9 is required for the formation
of some R-loops. Since DHX9 also unwinds RNA secondary
structures in vitro, including stable guanine quadruplexes, we
suggest that it is its ability of DHX9 to unwind RNA that best
explains its role in R-loop formation. This is supported by several
pieces of evidence. Firstly, DHX9 resolves RNA secondary
structures in cells to prevent Alu-mediated backsplicing36. Sec-
ondly, R-loop formation requires a free RNA end to promote
invasion and pairing of the nascent RNA with its complementary
duplex DNA43. This might be facilitated by DHX9-mediated
unwinding of RNA secondary structures to help assemble RNA
processing proteins on the nascent RNA strand. Thirdly, the role
of splicing factors and other RNA-binding proteins in preventing
R-loop formation is most easily explained if they bind to and
stabilize the nascent RNA strand, minimizing its potential to
invade DNA duplex. This last point is supported by our experi-
mental evidence showing that DHX9 is required for the binding
of splicing factors to nascent RNA as part of the elongating
transcription complex.
We have also established that the formation of R-loops
caused by impaired splicing correlates with the prolonged
association of DHX9 with RNA Pol II during transcription.
Whereas in normal cells, DHX9 associates with RNA poly-
merase II in the early phases of transcription, it is absent from
RNA Pol II at later stages of elongation. Importantly, the dis-
sociation of DHX9 from RNA Pol II is dependent on the
availability of the splicing factors SF3B3 and SFPQ. We hypo-
thesize that these proteins stabilize the unwound nascent RNA
strand, preventing it from forming further secondary struc-
tures. Since DHX9 does not bind single-stranded RNA41, this
would alleviate the requirement for DHX9 as transcription
progresses. Conversely, in the absence of splicing factors, DHX9
remains associated with the transcription complex where it
binds to RNA secondary structures that form in the nascent
strand and unwinds them during transcription elongation. The
disadvantage of this activity is that, in the absence of splicing
factors or components of RNP, the free “unstructured” RNA
end generated by DHX9 is available to invade DNA duplex
where it can form RNA–DNA hybrid and displaced ssDNA. As
transcription progresses, RNA–DNA strand exchange might
extend the region of RNA–DNA hybrid to generate an R-loop
along an entire coding region as we observed at the Β-actin
locus. This model, described in Fig. 10, raises the intriguing
possibility that it is the impact of splicing defects on tran-
scription, rather than a failure in RNA splicing per se, that
contributes to the generation of R-loops17. Interestingly, a
recent study using a conditional deletion of murine SFPQ
proposed that SFPQ, together with CDK9, facilitates tran-
scriptional elongation as well as activating RNA processing and
stabilizing pre-mRNA33.
In another study, mutations in yeast histones were shown to
promote the formation of R-loops without inducing DNA
damage, indicating that R-loops, per se, do not cause genome
instability46. We found that depletion of XRN2 in human cells
also induces R-loops but does not cause replication stress. This
raised the question, why do some R-loops cause replication stress
and genomic instability and others do not? Our data suggest that
R-loop formation can cause RNA polymerase to become tethered
to chromatin through RNA–DNA hybrid, where it has the
potential to block DNA replication. In contrast, R-loops gener-
ated upon depletion of XRN2 do not trap RNA Polymerase II
on chromatin and these cells do not exhibit replication stress.
This supports a model in which it is the retention of RNA
Polymerase on chromatin and the concomitant increased
b
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Fig. 7 DHX9 helicase activity is required for R-loop formation and growth
inhibition. a Expression of wild-type DHX9, but not a helicase-defective
mutant (pGFP-DHX9dead), promotes R-loop formation in SFPQ-defective
cells. Fluorescence intensity of S9.6 staining was measured for n > 50 cells.
Statistical signiﬁcance was determined using Mann–Whitney test (****p <
0.0001). b Expression of wild-type DHX9 but not a helicase-defective
mutant confers impaired cell proliferation in SFPQ-depleted cells
(siSFPQ8). Cell number was measured using a Casey Cell Counter 48 h
after transfection with siRNA (time 0) and again after 3, 5, and 7 days. c
RNA Pol II S2P was immunoprecipitated from Hela cell nuclear extracts and
co-puriﬁcation of different splicing factors was probed by western blot (as
indicated). Duplicate samples were treated with RNaseA as indicated to
demonstrate the requirement of RNA in these interactions
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transcription–replication collisions that are responsible for
pathological replication stress, rather than the generation of R-
loops per se.
It is important to note that DHX9 contributes to the processing
of genes transcribed by RNA Pol II48. Since R-loops can also be
generated during transcription by RNA polymerases I and III6,
there must be other mechanisms through which R-loops form. It
will be interesting to determine whether R-loops generated during
transcription by these by other polymerases also require the
activity of helicases, equivalent to DHX9, that unwind nascent
RNA.
In summary, our work identiﬁes DHX9 as a pivotal factor in
the formation of R-loops in cells with perturbed RNA splicing.
Our data also provide an explanation for the role of splicing
factors in the suppression of R-loops, by facilitating the dis-
sociation of DHX9 from RNA Pol II. In the absence of these
stabilizing factors, the generation of R-loops causes trapping of
RNA Pol II on chromatin creating a physical block to DNA
replication and increasing genome instability. Our work reveals
detailed new insights into the important interplay between
transcription, mRNA splicing, and DNA replication that might be
relevant to those neurodegenerative diseases and cancers that are
impaired in processing of pre-mRNAs.
Methods
Cell culture. HeLa and U2OS cell lines were cultured in Dulbecco’s modiﬁed
Eagle’s medium supplemented with 10% fetal bovine serum and appropriate
antibiotics and grown at 37 °C and 5% CO2. All cell lines were obtained from
ATCC.
Antibodies, chemicals, and cell-cycle reagents. Primary antibodies used in this
study: mouse anti-RPA32 (RPA2 Ab #2; Calbiochem) used at a dilution of 1:500 for
immunoﬂuorescence experiments (IF) and 1:1000 dilution in western blot (WB);
rabbit polyclonal anti-SFPQ (Bethyl Laboratories, A301–320A, IF 1:500, IP 4 μg/ml,
and WB 1:1000 dilution), mouse monoclonal anti-SFPQ antibody (Abcam, ab11825,
IF 1:500 and IP 3.5 μg/ml dilution), mouse monoclonal anti-GAPDH antibody
(GeneTex GT239, WB 1:1000 dilution), rabbit polyclonal anti-RNA polymerase II
antibody phospho-ser2 (Abcam, ab5095, IP:2 μg/ml and WB 1:1000 dilution), rabbit
Polyclonal anti-RNA polymerase II antibody phospho-ser5 (Abcam, ab52208, IP: 2
μg/ml and WB 1:1000 dilution), rabbit polyclonal anti-Chk1 [p Ser345] (Novus
Biologicals, WB 1:1000 dilution), rabbit Polyclonal anti-Phospho RPA32 (S4/S8)
Antibody (Bethyl Laboratories, A300-245AWB 1:1000 dilution), rabbit polyclonal
anti-RNA polymerase II antibody phospho-ser7 (Abcam, ab126537, IP: 2 μg/ml and
WB 1:1000 dilution), rabbit polyclonal anti-SF3B3 antibody (Abcam, ab96683, WB
1:1000 dilution), mouse monoclonal anti-γH2AX (ab26350, Abcam, IF 1:100 dilution
and WB 1:500 dilution), rabbit polyclonal anti-53BP1 Antibody (Novus Biologicals,
NB100-904 IF 1:500, WB 1:2000, IP 2mg/ml and NB100-304 IP 2mg/ml), rabbit
polyclonal anti-RNA Helicase A antibody (ab26271, WB 1:1000 dilution and IP 4mg/
ml), rabbit polyclonal anti-XRN2 Antibody (Cambridge Biosciences A301-103A, WB
1:1000 dilution), mouse monoclonal anti-RNase H1 antibody (ab56560, WB 1:1000
dilution) and rabbit polyclonal anti-nucleolin antibody (ab22758, WB 1:1000 dilu-
tion), rabbit monoclonal anti-SC35 (SRSF1) antibody (Abcam ab204916, WB 1:2000
dilution). For detecting DNA–RNA hybrid, mouse anti-DNA–RNA Hybrid [S9.6]
(Kerafast, ENH001, 1:100 dilution for IF and 1:1000 dilution for slot blot) was used
and mouse anti-DNA, single stranded (Merck Millipore, MAB3034 1:1000 dilution
for dot blot) to detect total ssDNA. Secondary antibodies: goat anti-mouse Alexa
Fluor-488 (Molecular Probes) was used at 1:200 dilution, and goat anti-rabbit alexa
ﬂuor 647 (Molecular Probes) was used at 1:200 dilution. EdU incorporation was
measured by using the Click-iT EdU Alexa Fluor 647 ﬂow cytometry kit (Life
Technologies) according to the manufacturer’s instructions. Hydroxyurea (H8627)
and Actinomycin D (A1410) were supplied by Sigma-Aldrich and Pladienolide B
(CAS 445493-23-2) was purchased from Santa-Cruz Biotechnology.
Plasmids. pSFPQ-myc is described in Rosonina et al.49. pCMV-DHX9-
GFPSPARK is designated pGFP-DHX9 and was purchased from Stratech (Sino-
Biologicals). pGFP-DHX9dead contains D511A and E512A mutations made by
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Fig. 8 DHX9 associates with different phosphorylated forms of RNA Polymerase II. aWestern blot of RNA Pol II and DHX9 immunoprecipitated from HeLa
cells with antibodies speciﬁc for phosphor-serine 2 (S2P) and phosphor-serine 5 (S5P) forms of RNA Pol II. Where indicated cells were transfected with
siRNA against a scrambled DNA sequence (siControl) or against SFPQ (siSFPQ8, siSFPQ9). b Expression of siRNA-resistant myc-SFPQ in SFPQ
knockdown cells promotes the association of DHX9 with RNA Pol II S5P and diminishes its association with S2P. c Chromatin immunoprecipitation of
DHX9 at the Β-actin locus. Data are depicted as fold enrichment over the control IP. qPCR of IP samples was performed for the primer pairs described in
Fig. 6a. Means and s.e.m. are plotted and data are an average from three independent replicates. d Chromatin immunoprecipitation of RNA Pol II S2P at the
Β-actin locus as described in c
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site-directed mutagenesis of pGFP-DHX9 using Q5 Site Directed Mutagenesis
system (New England Biolabs) according to the manufacturer’s instructions.
SiRNA. The siRNAs were purchased from Dharmacon-ON-TARGETplus. Non-
targeting siRNA D-001810-01-05; SFPQ-J-006455-06 J-006455-08 J-006455-09;
SFPQ utr DUPLEX STD CTM-64991; SF3B3-J-20085-08; DHX9-J-009950-06
DHX9utr CTM-310164; RNASEH1-J-012595-09; XRN2- J-017622-12
qPCR primers. Primers used for qPCR analysis of the Β-actin locus are described
in Kaneko et al.39.
Region A: (fwd) cccacctgacaacctctcat, (rev) cccttcttgctgcctgtt
Promoter: (fwd) ctcaatctcgctctcgctct, (rev) ctcgagccataaaaggcaac
Region B: (fwd) caactgggacgacatggagaaa, (rev) gagtcctacggaaaacggcaga
Region C: (fwd) gcgcacagtaggtctgaaca, (rev) agaggcgtacagggatagca
Poly(A): (fwd) tgtacactgacttgagaccagt, (rev) aagcaggaacagagacctgacc
Region D: (fwd) taggcttaggagaggccgcaat, (rev) gtccaggagcctgggtatctcc
Region E: (fwd) gaggcctggactctcaactg, (rev) ggtccttgtccaggtcatct
Region F: (fwd) caaccagatgtgttccgtgt, (rev) ctacacctgcaagaccacca
Region G: (fwd) actgctgacattggtgatgc, (rev) agtaggtggtggcagcagac
Region H: (fwd) tgtctcagaggcatggattg, (rev) ccgctacagtcaccttccag
Primers used for DRIP at the centromeric region of Chromosome 1 are
described in Kabeche et al.2.
c1 centro (fwd) tcattcccacaaatgcgttg, (rev) tccaacgaatgggaaaggagtc
c1 pericentro (fwd) catcgaatggaaatgaaaggagtc, (rev) accattggatgattgcagtcaa
snrpn (fwd) gccaaatgagtgaggatggt, (rev) tcctctctgcctgactccat
Cell fractionation. Brieﬂy, 3 × 106 HeLa cells per condition were collected and
suspended in 250 µl of buffer A (10 mM HEPES pH 7.8, 10 mM KCl, 1.5 mM
MgCl2, 0.25 M sucrose, 10% glycerol, 1 mM DTT, 0.1% Triton X-100, protease and
phosphatase inhibitors) and incubated for 5 min on ice. The soluble cytoplasmic
fraction (S1) was separated from the nuclei (P2) by centrifugation for 4 min at
2000 × g at 4 °C. The nuclear fraction P2 was washed twice with 500 µl buffer A and
suspended in 200 µl buffer B (3 mM EDTA, 0.2 mM EGTA, 1 mM DTT, phos-
phatase, and protease inhibitors) and incubated at 4 °C for 30 min. The insoluble
chromatin fraction (P3) was separated from nuclear soluble proteins (S3) by
centrifugation for 4 min at 1700 × g at 4 °C. S1 was cleared from insoluble proteins
by centrifugation at 16,000 × g in a benchtop micro-centrifuge for 30 min at 4 °C
and the supernatant (S2) was kept for analysis. Cell fractions were subsequently
analyzed by the Novex transfer system (Invitrogen) and western blotting.
Immunoprecipitation. Prior to immunoprecipitation, primary antibody was
incubated with Dynabeads protein G beads (Novex, Invitrogen) for 2–4 h at 4 °C.
Nuclei were prepared as described above. For immunoprecipitation of DHX9,
nuclei were lysed using Lysis Buffer (150 mM NaCl, 0.5% Triton X-100, 50 mM
Tris-HCl pH 7.5, 1 mM EDTA, 5% glycerol, and 0.1% SDS) supplemented with
protease and phosphatase inhibitor cocktails (Thermoscientiﬁc). Extracts were
passed through 23G needle for 10 min, and incubated with rocking at 4 °C for 30
min. Extracts were centrifuged at 16,000 × g for 15 min in a microfuge and the
supernatant was collected. For immunoprecipitation of RNA Pol II (phospho-ser-
2), nuclei were lysed in Nuclear Lysis buffer (100 mM Tris pH 7.5, 350 mM NaCl,
1% Triton X-100 and 10% glycerol). DNA in the extract was digested overnight by
the addition of 50 units each of BamHI, NcoI, PvuII, ApaLI, NheI, XbaI, XmnI, and
DraI. The supernatant was cleared by centrifugation at 16,000 × g for 15 min and
extracts were left untreated or treated with RNaseA (10 mg/ml).
Extract was added to the antibody-Dynabead complex and then incubated with
rotation for 4 h to overnight at 4 °C. Immunocomplexes were separated using a
magnet, washed three times in lysis buffer, boiled in sample buffer, and loaded on a
4–12% Bis-Tris polyacrylamide gel (Invitrogen). Proteins were transferred to PVDF
membrane using a Novex transfer system (Invitrogen) and immunoblotted using
the indicated antibodies.
Immunoﬂuorescence microscopy. For EdU incorporation, U2OS cells were see-
ded onto coverslips and transfected with the indicated siRNA and grown up to 96
h. At the indicated times 10 μm EdU was added and incubation continued for a
further 1 h before cells were harvested. Coverslips containing ﬁxed cells were
washed with phosphate-buffered saline (PBS) and stained using the Click-iT EdU
Alexa Fluor 647 Flow cytometry kit (Life Technologies) according to the manu-
facturer’s instructions. For detection of nuclear foci, cells were pre-extracted for 5
min on ice in 25 mM Hepes pH 7.4, 50 mM NaCl, 1 mM EDTA, 3 mMMgCl2, 300
mM sucrose, and 0.5% Triton X-100, after which they were ﬁxed using 4% for-
maldehyde (w/v) in PBS for 15 min. Cells were then washed three times in PBS and
permeabilized for 10 min in 0.5% Triton X-100/PBS. Three additional PBS washes
were performed, after which cells were blocked using 1–3% bovine serum albumin
siC
on
tro
l
siS
FP
Q
siD
HX
9
siS
FP
Qs
iDH
X9
siC
on
tro
l
siS
FP
Q
siD
HX
9
siS
FP
Qs
iDH
X9
Soluble Pellet
DHX9
RNA Pol II S2P
a
Soluble Pellet
b
siC
on
tro
l
siS
FP
Q
siS
F3
B3
siS
FP
Q
siC
on
tro
l
siC
on
tro
l
siS
FP
Q
siS
F3
B3
siS
F3
B3
RNA Pol II S2P
LaminA
GAPDH
Soluble Pellet
RNA Pol II S2P
LaminA
GAPDH
siC
on
tro
l
siX
RN
2
siD
HX
9
siX
RN
2D
HX
9
siC
on
tro
l
siX
RN
2
siD
HX
9
siX
RN
2D
HX
9c
225 kDa
225 kDa
115 kDa
225 kDa
35 kDa
65 kDa
35 kDa
65 kDa
++– – RNaseH+––– –
Fig. 9 DNA–RNA hybrid traps RNA Polymerase II on chromatin. a Depletion of SFPQ and SF3B3 causes retention of RNA Pol II on chromatin that is
released by treatment with RNAseH1. Western blot of soluble (cytoplasmic) and insoluble (pellet) fractions of nuclear extracts prepared from HeLa cells
that were knocked down with siRNAs against the indicated genes. Blots were also probed for GAPDH and LaminA to validate cytoplasmic and chromatin
pellet fractions, respectively. b As in a showing that knockdown of DHX9 in cells depleted of SFPQ reverses the retention of RNA Pol II S2P on chromatin.
c RNA Pol II (S2P) is not retained in the insoluble chromatin pellet from cells knocked down for XRN2
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(BSA)/PBS for 30 min. Cells were incubated with primary antibody (as indicated
above), followed by the addition of Alexa Fluor-488 or -594 conjugated secondary
antibodies (1:1000). To visualize nuclei, cells were also stained with 0.5 μg/ml DAPI
(Molecular Probes). Slides were mounted using Prolong gold anti-fade reagent
(Invitrogen) and images were acquired using a Deltavision DV4 wide-ﬁeld
deconvolution microscope with a ×100 objective.
To detect DNA–RNA hybrid, cells were stained with S9.6 antibody as
described27. Cells were co-stained with antibody against nucleolin, which was used
to mask nucleolar regions for quantiﬁcation of S9.6 staining. The nuclear
S9.6 signal was determined subtracting the S9.6 staining intensity of the region co-
stained with nucleolin from the total nuclear S9.6 stain. Images were analyzed using
a DeltaVision microscope and quantiﬁed using image J software.
Cell growth assay. U2OS cells were transfected with siRNA for 48 h and 50,000
cells were seeded into a six-well plate (time 0). At the indicated times, cells were
recovered from the monolayer using trypsin and counted using the Casey Cell
Counter. Growth curves were plotted using data from three independent biological
replicates.
Cell-cycle analysis. Cells were grown for 1 h in medium supplemented with 10 μm
BrdU. Cells were ﬁxed using ethanol and the DNA was denatured using 1 ml of 2 N
HCl/Triton X-100 and then neutralized with 500 μl 0.1 M Na2B4O7. Cells were
blocked using PBS/1% BSA/0.5% Tween-20 and incubated with mouse anti-BrdU
primary antibody (clone BU20A, Dako) followed by goat anti-mouse FITC-con-
jugated secondary antibody (DAKO). Cells were suspended in 1 ml of PBS con-
taining 5 μg/ml propidium iodide and 5 μl RNAse (25 mg/ml), incubated at room
temperature for 30 min, and analyzed by FACS. Cell-cycle distribution was mea-
sured by ﬂow cytometry in a Fortessa ﬂow cytometer (Becton Dickinson) and
analyzed using FlowJo software (FlowJo).
Annexin-V assay. Apoptotic cell death was analyzed using Annexin-V kit
(ebiosciences) as described by the manufacturer and quantiﬁed using a Nucleo-
Counter NC-3000 system (Chemomotek).
DNA–RNA immunoprecipitation. DRIP was performed using HeLa cells trans-
fected with the indicated siRNAs. Brieﬂy, each immunoprecipitation used 10 × 106
cells that were lysed in cell lysis buffer (1M KCL, 100 mM HEPES pH 7.8 and 1%
Triton X-100) for 5–10 min on ice. Cells were washed with PBS, collected by
centrifugation and the collected nuclei lysed in nuclei lysis buffer (1M Tris pH 8,
0.1 M EDTA and 10% SDS). Proteinase K (10 mg/ml) was added and nuclei pellet
were incubated at 37 °C overnight. Nucleic acid was precipitated using ethanol and
digested overnight by the addition of 50 units each of BamHI, NcoI, PvuII, ApaLI,
NheI, XbaI, XmnI, and DraI. Digested nucleic acid was treated with RNaseA (10
mg/ml) and 5M NaCl for 2 h at 37 °C to remove contaminating ssRNA. DNA:
RNA hybrids were precipitated using glycogen and isopropanol. Nucleic acid was
puriﬁed with phenol–chloroform and precipitated with ethanol. The DNA was
rehydrated in 250 μl water and quantiﬁed with a Nanodrop spectrophotometer.
Fifty microliters was stored as the “input” sample. Ten micrograms of nucleic acid
was treated with 25 U RNaseH1 to digest DNA–RNA hybrid and serve as a
negative control. Five micrograms of RNAseH1 treated and untreated nucleic acid
was immunoprecipitated using 10 μg S9.6 antibody and 50 μl with Dynabeads
Protein G and made up to 500 μl with binding buffer (1 M Na-phosphate pH 7, 5
M NaCl, and 10% Triton X-100) and incubated overnight at 4 °C. IPs were then
washed several times with wash buffer (1M Tris pH 8, 500 mM EDTA, 10% SDS,
10% Triton X-100, 5 M NaCl). Nucleic acid were eluted with 100 mM NaHCO3
and 1% SDS along with addition of 3 μl RNaseA for 2 h at 65 °C followed by
incubation with Proteinase K (10 mg/ml). Proteins were removed from the sample
by phenol–chloroform extraction and ethanol precipitation. Control IP was per-
formed using 10 μg of anti-mouse IgG antibody. Quantitative PCR was performed
using Fast SYBR™ Green Master Mix (Applied Biosystems) with the indicated
primers and samples were ampliﬁed using an Applied Biosystems 7500 Real-Time
DHX9
Nacent transcript
DNA polymerase
DHX9
DHX9
DHX9
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Fig. 10 DHX9 promotes the generation of R-loops. Model showing how DHX9 promotes the formation of R-loops by unwinding the nascent RNA to
generate the free RNA end, which is required for the invasion of duplex DNA and generation of DNA–RNA hybrid. RNA-binding proteins prevent R-loop
formation by binding to the nascent RNA inhibiting its ability to pair with its complementary DNA template. In the absence of RNA-binding proteins, the
free RNA end that is generated by DHX9 is available for R-loop formation. This may lead to RNA Pol II becoming trapped on chromatin where it can pose a
barrier to DNA replication and increases the likelihood of transcription–replication conﬂicts. In the absence of DHX9, the formation of secondary structures
in the nascent RNA prevent it from invading the DNA duplex to form R-loops
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PCR System. The data were expressed as fold enrichment of each primer region in
the experimental sample over the negative control. The mean and s.e.m. was
plotted from three independent experiments and statistical analysis was performed
using one-way ANOVA. The list of primers are provided above.
Slot blot. Preparation of nucleic acids was as described for DRIP with a few
modiﬁcations. Brieﬂy, after overnight digestion with restriction enzymes half of the
nucleic acid sample was treated with RnaseH1 (20 U) every 3 h. The other half of
the sample was treated with denaturation buffer (0.5 N NaOH and 1.5 M NaCl)
and then neutralized with 1M NaCl and 0.5 M Tris-HCl pH 7.0. In all, 0.5, 1, and
2 μg aliquots of nucleic acids were loaded onto a nylon membrane using a Biorad
slot blot manifold and then crosslinked using a Uvitech (Cambridge) Stratalinker
(0.12 J/m2). Membranes were blocked in 5% Milk with PBST and probed overnight
at 4 °C with S9.6 antibody (diluted 1:1000) and anti-mouse ssDNA antibody
(1:5000) and then probed with goat anti-mouse antibody secondary antibody. The
membrane was washed three times with PBST and exposed to X-ray ﬁlm. The
image is normalized to the control sample (set to 1) and quantiﬁed using Image J
software.
Chromatin immunoprecipitation. 1–5 × 107 HeLa cells were transfected with
siRNA for 48–72 h, washed, and crosslinked with 0.5–1% formaldehyde at room
temperature for 10 min for RNA Pol II and 3% formaldehyde at room tem-
perature for DHX9 immunoprecipitation. One hundred and twenty-ﬁve milli-
molar glycine was added directly to cells in 15 cm dishes and incubated for
another 5 min with shaking. Cells were washed and harvested in cold PBS. Cells
were collected by centrifugation at 1000 × g for 5 min at 4 °C and suspended in
lysis buffer (50 mM HEPES-KOH pH 7.5, 140 mM NaCl, 1 mM EDTA pH 8, 1%
Triton X-100, 0.1% sodium deoxycholate 0.1% SDS and Protease Inhibitors
cocktail). Lysate was digested overnight with the addition of 50 units each of
BamHI, NcoI, PvuII, ApaLI, NheI, XbaI, XmnI, and DraI. The lysate was cen-
trifuged at 15,700 rcf for 15 min in a benchtop microfuge and the supernatant
collected. Twenty-ﬁve microliters of Dynabeads coupled to 4 μg anti-DHX9
antibody was added to 500 μl supernatant and incubated with rotation at 4 °C
overnight. Antibody was omitted from one sample as a control. Immunocom-
plexes were separated using a magnet, washed three times in lysis buffer, and
DNA eluted in 200 mM glycine for 5 min and then boiled for 10 min. Immu-
nocomplexes were incubated with 30 units RNase A for 30 min at 37 °C followed
by proteinase K for 45 min at 55 °C. DNA was puriﬁed with phenol–chloroform
and quantiﬁed using a Nanodrop spectrophotometer (Thermo-Fisher). Quan-
titative PCR was performed using standard protocols in an ABI PRISM 7900
(Applied Biosystems) using Fast SYBR Green Master Mix (Applied Biosystems).
Analysis was carried out using the delta Ct method (fold enrichment). The mean
and s.e.m. was plotted from three independent experiments and statistical sig-
niﬁcance determined using one-way Anova.
Data processing and statistical analysis. Values are shown with the standard
deviation from three independent experiments unless indicated otherwise. Data
were analyzed and, where appropriate, the signiﬁcance of the differences between
the mean values was determined using two-tailed Students t-test (*p ≤ 0.05),
Mann–Whitney unpaired t-test (**p ≤ 0.01, ****p ≤ 0.0001) or one-way Anova test
as indicated. All statistics were performed using Prism v6 (GraphPad Software).
Data availability
The data that support the ﬁndings of this study are available from the corresponding
author upon reasonable request.
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